Epicardial Adipose Tissue As New Cardio-Metabolic Risk Marker and Potential Therapeutic Target in the Metabolic Syndrome

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|21|2180-2184

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.21, 2007-01, pp. : 2180-2184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolic Syndrome and Adipose Tissue: New Clinical Aspects and Therapeutic Targets

By  

Current Pharmaceutical Design, Vol. 13, Iss. 21, 2007-07 ,pp. : 2148-2168

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor (PPAR)&bgr; /&dgr;: A New Potential Therapeutic Target for the Treatment of Metabolic Syndrome

By  

Current Molecular Pharmacology, Vol. 2, Iss. 1, 2009-01 ,pp. : 46-55

Bentham Science Publishers

Access to resources Recommend Favorite

Adipose Tissue as a Target of HIV-1 Antiretroviral Drugs. Potential Consequences on Metabolic Regulations

By  

Current Pharmaceutical Design, Vol. 16, Iss. 30, 2010-10 ,pp. : 3352-3360

Bentham Science Publishers

Access to resources Recommend Favorite

Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment

By Garruti Gabriella   Depalo Raffaella   Vita Maria Grazia   Lorusso Filomenamila   Giampetruzzi Federica   Damato Aurelia Bellomo   Giorgino Francesco  

Reproductive BioMedicine Online, Vol. 19, Iss. 4, 2009-10 ,pp. : 552-563

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Tissue-specific Cushing's syndrome uncovers a new target in treating the metabolic syndrome – 11β-hydroxysteroid dehydrogenase type 1

By Stewart Paul M  

Clinical Medicine, Vol. 5, Iss. 2, 2005-03 ,pp. : 142-146

Royal College Of Physicians

Access to resources Recommend Favorite